Finance

Beta
Lists
LSL:CVE
LSL Pharma Group Inc
CA$0.33
0.00%
(0.00) 1D
Jun 3, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for LSL...
Open
CA$0.33
High
CA$0.33
Low
CA$0.33
Mkt. cap
41.82M
Avg. vol.
115.72K
Volume
2.22K
52-wk high
CA$0.56
52-wk low
CA$0.30
EPS
-CA$0.04
Beta
-0.21
Shares outstanding
126.73M
No. of employees
185
Open
CA$0.33
High
CA$0.33
Low
CA$0.33
Mkt. cap
41.82M
Avg. vol.
115.72K
Volume
2.22K
52-wk high
CA$0.56
52-wk low
CA$0.30
EPS
-CA$0.04
Beta
-0.21
Shares outstanding
126.73M
No. of employees
185
News stories
From sources across the web
About LSL Pharma Group Inc
CEO-
Employees185
Founded2010
Headquarters-
SectorPersonal care products
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Revenue
5.38M
6.92M
7.22M
7.58M
Cost of goods sold
3.91M
4.84M
5.16M
5.24M
Cost of revenue
3.91M
4.84M
5.16M
5.24M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.34M
1.69M
1.72M
1.85M
Operating expense
1.26M
1.72M
1.76M
1.94M
Total operating expenses
5.17M
6.55M
6.91M
7.18M
Operating income
216.00K
368.50K
304.00K
394.00K
Other non operating income
122.00K
-75.00K
-82.00K
-
EBT including unusual items
4.55M
-272.00K
-389.00K
-1.18M
EBT excluding unusual items
-336.00K
-272.00K
-389.00K
-423.00K
Income tax expense
50.00K
-
-
-
Effective tax rate
1.10%
-
-
-
Other operating expenses
-
-
-
-
Net income
4.50M
-272.00K
-389.00K
-1.18M
Net profit margin
83.55%
-3.93%
-5.39%
-15.58%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-674.00K
-565.50K
-611.00K
-817.00K
Net interest expenses
-674.00K
-565.50K
-611.00K
-817.00K
Depreciation and amortization charges
-102.00K
-
-
-
EBITDA
481.00K
957.50K
1.01M
1.10M
Gain or loss from assets sale
47.00K
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more